Published in Psychopharmacology (Berl) on October 31, 2013
The role of brain-derived neurotrophic factor in comorbid depression: possible linkage with steroid hormones, cytokines, and nutrition. Front Psychiatry (2014) 0.85
Pharmacotherapy of postpartum depression: an update. Expert Opin Pharmacother (2014) 0.80
Perinatal depression: an update and overview. Curr Psychiatry Rep (2014) 0.77
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry (1987) 32.05
The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58
Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol (2005) 8.67
Recognizing and treating peripartum depression. Dtsch Arztebl Int (2012) 3.96
A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ (1997) 3.30
Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept. Br J Psychiatry (1995) 2.77
Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol (2006) 2.64
Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol (2011) 2.34
The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry (2004) 1.95
Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry (2001) 1.75
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A (1999) 1.51
A meta-analysis of treatments for perinatal depression. Clin Psychol Rev (2011) 1.43
The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1996) 1.35
Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev (2005) 1.34
Interactive regulation of affect in postpartum depressed mothers and their infants: an overview. Psychopathology (2004) 1.34
Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry (2001) 1.24
Postpartum anxiety and depression: onset and comorbidity in a community sample. J Nerv Ment Dis (1998) 1.19
Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab (2000) 1.16
Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp (2012) 1.12
Prospective study of postpartum depression: 4 1/2-year follow-up of women and children. J Abnorm Psychol (1991) 1.11
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry (2008) 1.09
Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin (2009) 1.08
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. Int Clin Psychopharmacol (2010) 1.08
Postpartum anxiety and maternal-infant health outcomes. Pediatrics (2013) 1.06
Antenatal depression and anxiety affect postpartum parenting stress: a longitudinal, prospective study. Can J Psychiatry (2010) 1.01
The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J Clin Psychiatry (2003) 0.96
Clinical pharmacokinetics of sertraline. Clin Pharmacokinet (2002) 0.93
Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Pediatrics (2003) 0.90
Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol (2005) 0.90
Sertraline and breast-feeding. N Engl J Med (1997) 0.89
A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess (2010) 0.88
Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med (2010) 0.87
Role functioning and symptom remission in women with postpartum depression after antidepressant treatment. Arch Psychiatr Nurs (2003) 0.86
Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol (2011) 0.83
The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2012) 0.81
Restoration of functionality in postpartum depressed mothers: an open-label study with escitalopram. J Clin Psychopharmacol (2012) 0.80
A developmental decline in the learning-promoting effects of infant-directed speech for infants of mothers with chronically elevated symptoms of depression. Infant Behav Dev (2012) 0.78
Effects of postpartum anxiety disorders and depression on maternal self-confidence. Infant Behav Dev (2012) 0.78
Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry (2004) 3.64
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology (2004) 2.87
Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry (2008) 2.86
Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biol Psychiatry (2007) 2.58
Declining use of electroconvulsive therapy in United States general hospitals. Biol Psychiatry (2012) 2.50
Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol Psychiatry (2009) 2.44
Rates of violence in patients classified as high risk by structured risk assessment instruments. Br J Psychiatry (2014) 2.22
Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging. Biol Psychiatry (2009) 2.20
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry (2005) 2.14
A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry (2014) 2.10
Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry (2002) 2.01
Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry (2004) 1.96
Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol (2009) 1.90
Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol Psychiatry (2004) 1.90
Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS One (2012) 1.89
A prospective examination of distress tolerance and early smoking lapse in adult self-quitters. Nicotine Tob Res (2009) 1.87
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res (2007) 1.86
Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry (2003) 1.81
Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol Psychiatry (2008) 1.80
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry (2003) 1.77
Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry (2008) 1.76
Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder. Psychopharmacology (Berl) (2005) 1.67
Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry (2012) 1.67
Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. J Clin Psychiatry (2015) 1.62
DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients. Leuk Res (2013) 1.60
Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology (2010) 1.56
Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol (2005) 1.55
Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry (2005) 1.55
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry (2005) 1.52
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry (2005) 1.52
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology (2008) 1.49
Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry (2010) 1.47
The current crisis of confidence in antidepressants. J Clin Psychiatry (2011) 1.44
A meta-analysis of treatments for perinatal depression. Clin Psychol Rev (2011) 1.43
Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial. J Consult Clin Psychol (2011) 1.43
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet (2006) 1.41
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) (2004) 1.38
Effect of childhood physical abuse on cortisol stress response. Psychopharmacology (Berl) (2010) 1.34
Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev (2005) 1.34
Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry (2005) 1.33
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) (2010) 1.31
Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biol Psychiatry (2009) 1.30
Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl) (2011) 1.30
Sex differences in emotional and physiological responses to the Trier Social Stress Test. J Behav Ther Exp Psychiatry (2007) 1.24
Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry (2002) 1.23
The role of negative affect in risk for early lapse among low distress tolerance smokers. Addict Behav (2008) 1.23
Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin N Am (2003) 1.20
Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry (2004) 1.20
Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry (2011) 1.20
Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am J Psychiatry (2007) 1.17
Relapse of major depression in women who continue or discontinue antidepressant medication during pregnancy. Am J Psychiatry (2013) 1.16
A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch Gen Psychiatry (2002) 1.16
Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration. Biol Psychiatry (2006) 1.13
Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp (2012) 1.12
Utilization and barriers to mental health services among depressed medical interns: a prospective multisite study. J Grad Med Educ (2010) 1.10
Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry (2005) 1.10
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health (2011) 1.09
Varenicline augmentation in depressed smokers: an 8-week, open-label study. J Clin Psychiatry (2009) 1.09
123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase. J Nucl Med (2007) 1.08
Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression. Biol Psychiatry (2013) 1.08
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol Psychiatry (2002) 1.08
Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology (2002) 1.08
Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry (2006) 1.07
Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl) (2006) 1.06
An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry (2002) 1.06
Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar. Alcohol Clin Exp Res (2007) 1.05
The clinical correlates of reported childhood sexual abuse: an association between age at trauma onset and severity of depression and PTSD in adults. J Child Sex Abus (2010) 1.04
Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage (2006) 1.04
Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol Clin Exp Res (2007) 1.03
The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study. Neuropsychopharmacology (2012) 1.03
The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology (2013) 1.02
Gelatin "shots" as a new method for alcohol administration in a laboratory setting. Alcohol Clin Exp Res (2006) 1.02
Decreased default network connectivity is associated with early life stress in medication-free healthy adults. Eur Neuropsychopharmacol (2012) 1.02
Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. Psychol Assess (2010) 1.01
Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry (2008) 1.01
Posttraumatic stress disorder and substance use in inner-city adolescent girls. J Nerv Ment Dis (2003) 1.01
Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology (2011) 1.00
A paradigm to investigate the self-regulation of cocaine administration in humans. Psychopharmacology (Berl) (2005) 0.99
Elevated risk of adverse obstetric outcomes in pregnant women with depression. Arch Womens Ment Health (2013) 0.99
Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr (2004) 0.98
Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults. Psychoneuroendocrinology (2006) 0.97
Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas. Am J Dermatopathol (2012) 0.97
Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. Drug Alcohol Depend (2006) 0.96
Prenatal programming of mental illness: current understanding of relationship and mechanisms. Curr Psychiatry Rep (2015) 0.96
Using computational patients to evaluate illness mechanisms in schizophrenia. Biol Psychiatry (2011) 0.95
The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Arch Gen Psychiatry (2011) 0.95
The relationship between childhood abuse and adult personality disorder symptoms. J Pers Disord (2007) 0.94
Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord (2010) 0.94
Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking. Arch Gen Psychiatry (2005) 0.94
Self-reported paranoia during laboratory "binge" cocaine self-administration in humans. Pharmacol Biochem Behav (2006) 0.94
The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment. Epilepsy Behav (2008) 0.93
Childhood parental loss and adult psychopathology: effects of loss characteristics and contextual factors. Int J Psychiatry Med (2008) 0.93
Inter-rater reliability and concurrent validity of DSM-IV opioid dependence in a Hmong isolate using the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). Addict Behav (2010) 0.93
Cortisol and ACTH responses to the Dex/CRH test: influence of temperament. Horm Behav (2008) 0.93
A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. J Affect Disord (2010) 0.92